365 related articles for article (PubMed ID: 15694337)
1. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation.
Bennett EJ; Bence NF; Jayakumar R; Kopito RR
Mol Cell; 2005 Feb; 17(3):351-65. PubMed ID: 15694337
[TBL] [Abstract][Full Text] [Related]
2. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
Schipper-Krom S; Juenemann K; Jansen AH; Wiemhoefer A; van den Nieuwendijk R; Smith DL; Hink MA; Bates GP; Overkleeft H; Ovaa H; Reits E
FEBS Lett; 2014 Jan; 588(1):151-9. PubMed ID: 24291262
[TBL] [Abstract][Full Text] [Related]
3. Testing the possible inhibition of proteasome by direct interaction with ubiquitylated and aggregated huntingtin.
Valera AG; Díaz-Hernández M; Hernández F; Lucas JJ
Brain Res Bull; 2007 Apr; 72(2-3):121-3. PubMed ID: 17352935
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ
J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
[TBL] [Abstract][Full Text] [Related]
5. Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease.
Mitra S; Tsvetkov AS; Finkbeiner S
J Biol Chem; 2009 Feb; 284(7):4398-403. PubMed ID: 19074152
[TBL] [Abstract][Full Text] [Related]
6. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation.
Ortega Z; Díaz-Hernández M; Maynard CJ; Hernández F; Dantuma NP; Lucas JJ
J Neurosci; 2010 Mar; 30(10):3675-88. PubMed ID: 20220001
[TBL] [Abstract][Full Text] [Related]
7. Impairment of the ubiquitin-proteasome system by protein aggregation.
Bence NF; Sampat RM; Kopito RR
Science; 2001 May; 292(5521):1552-5. PubMed ID: 11375494
[TBL] [Abstract][Full Text] [Related]
8. Inefficient degradation of truncated polyglutamine proteins by the proteasome.
Holmberg CI; Staniszewski KE; Mensah KN; Matouschek A; Morimoto RI
EMBO J; 2004 Oct; 23(21):4307-18. PubMed ID: 15470501
[TBL] [Abstract][Full Text] [Related]
9. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
Verhoef LG; Lindsten K; Masucci MG; Dantuma NP
Hum Mol Genet; 2002 Oct; 11(22):2689-700. PubMed ID: 12374759
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent reporters for the ubiquitin-proteasome system.
Salomons FA; Verhoef LG; Dantuma NP
Essays Biochem; 2005; 41():113-28. PubMed ID: 16250901
[TBL] [Abstract][Full Text] [Related]
11. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
von Mikecz A; Chen M; Rockel T; Scharf A
Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
[TBL] [Abstract][Full Text] [Related]
12. Application and analysis of the GFPu family of ubiquitin-proteasome system reporters.
Bence NF; Bennett EJ; Kopito RR
Methods Enzymol; 2005; 399():481-90. PubMed ID: 16338377
[TBL] [Abstract][Full Text] [Related]
13. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
Stenoien DL; Mielke M; Mancini MA
Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
[TBL] [Abstract][Full Text] [Related]
14. Polyglutamine-mediated aggregation and cell death.
de Cristofaro T; Affaitati A; Feliciello A; Avvedimento EV; Varrone S
Biochem Biophys Res Commun; 2000 Jun; 272(3):816-21. PubMed ID: 10860836
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells.
Kyratzi E; Pavlaki M; Kontostavlaki D; Rideout HJ; Stefanis L
J Neurochem; 2007 Aug; 102(4):1292-303. PubMed ID: 17472700
[TBL] [Abstract][Full Text] [Related]
16. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic.
Takahashi T; Kikuchi S; Katada S; Nagai Y; Nishizawa M; Onodera O
Hum Mol Genet; 2008 Feb; 17(3):345-56. PubMed ID: 17947294
[TBL] [Abstract][Full Text] [Related]
17. Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease.
Hipp MS; Patel CN; Bersuker K; Riley BE; Kaiser SE; Shaler TA; Brandeis M; Kopito RR
J Cell Biol; 2012 Mar; 196(5):573-87. PubMed ID: 22371559
[TBL] [Abstract][Full Text] [Related]
18. Intranuclear degradation of polyglutamine aggregates by the ubiquitin-proteasome system.
Iwata A; Nagashima Y; Matsumoto L; Suzuki T; Yamanaka T; Date H; Deoka K; Nukina N; Tsuji S
J Biol Chem; 2009 Apr; 284(15):9796-803. PubMed ID: 19218238
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates.
Donaldson KM; Li W; Ching KA; Batalov S; Tsai CC; Joazeiro CA
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8892-7. PubMed ID: 12857950
[TBL] [Abstract][Full Text] [Related]
20. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.
Kaytor MD; Wilkinson KD; Warren ST
J Neurochem; 2004 May; 89(4):962-73. PubMed ID: 15140195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
